Fly News Breaks for September 13, 2019
Sep 13, 2019 | 06:57 EDT
Cantor Fitzgerald analyst Craig Bijou expects the American Society for Radiation Oncology annual meeting, being held September 15-19 in Chicago, to be positive for ViewRay. He believes conference buzz will be centered on the radiation oncology alternative payment model, the overall competitive environment, and clinical data. ViewRay will have an opportunity to raise its exposure to the industry, says Bijou, who reiterates an Overweight rating on the shares with a $6 price target.
News For VRAY From the Last 2 Days
There are no results for your query VRAY